Official Publications Acticor Biotech SAS

Equities

End-of-day quote Euronext Paris Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
0.688 ^EUR	-4.44%		-18.48%	-76.28%

05-15	Acticor: 'new perspectives' in stroke treatment	CF
05-15	Acticor Biotech Announces Presentation of the Main Results of the Phase 2/3 Actisave Study in the Treatment of Stroke at ESOC 2024	CI

Monthly statement on voting rights	30/12/22	CO
Monthly statement on voting rights	30/12/22	CO
Provisional calendar	30/11/22	CO
Provisional calendar	30/11/22	CO
Monthly statement on voting rights	29/11/22	CO
1st-half-year results	26/10/22	CO
1st-half-year results	26/10/22	CO
Half-year report	26/10/22	CO
Half-year report	26/10/22	CO
Monthly statement on voting rights	29/09/22	CO
Monthly statement on voting rights	29/09/22	CO
Monthly statement on voting rights	30/08/22	CO
Monthly statement on voting rights	30/08/22	CO
Monthly statement on voting rights	30/07/22	CO
Monthly statement on voting rights	30/07/22	CO
Monthly statement on voting rights	29/06/22	CO
Monthly statement on voting rights	29/06/22	CO
Monthly statement on voting rights	30/05/22	CO
Monthly statement on voting rights	30/05/22	CO
Monthly statement on voting rights	29/04/22	CO
Monthly statement on voting rights	29/04/22	CO
Monthly statement on voting rights	30/03/22	CO
Monthly statement on voting rights	30/03/22	CO
Changes in management and corporate officers	07/03/22	CO
Monthly statement on voting rights	27/02/22	CO